NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Description
Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026
Offer reference number: CM/TNS/25/5736
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/25/5736 Nintedanib and Dalbavancin
Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months)
Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months)
Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
The rest of this notice
The tender documents, the buyer's named contact and the award history for this notice are free. Create an account to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Get alerts for tenders like this one
Free — no card, no trial clock.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.